Home Nucleus Pharmaceuticals Malaysia Influenza Drug Market to 2032

Malaysia Influenza Drug Market to 2032

Overview

The Malaysia Influenza Drug Market is expected to reach a 184.00 USD Million by 2032 and is projected to grow at a CAGR of 6.39% from 2025 to 2032.

Revenue, 2024 (USD Million)
123.29
Forecast, 2032 (USD Million)
184.00
CAGR, 2024 - 2032
6.39%
Report Coverage
Malaysia

Malaysia Influenza Drug Market 2018-2032 USD Million

Malaysia Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 123.29 USD Million
  • Projected Market Size (2032): 184.00 USD Million
  • CAGR (2025-2032): 6.39%

Key Findings of Malaysia Influenza Drug Market

  • The Malaysia Influenza Drug Market was valued at 123.29 USD Million in 2024.
  • The Malaysia Influenza Drug Market is likely to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 214.52 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.18% during the forecast period from 2024 to 2032.

Malaysia Influenza Drug Market Scope

Malaysia Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Type
  • Influenza C
  • Influenza B
  • Influenza A
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender

Malaysia Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 123.29 USD Million
Market Value in 2032 184.00 USD Million
CAGR (2025-2032) 6.39%
Historic Data 2016-2023
Market Segments Covered Treatment,Type,Route of Administration,Age,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Malaysia, leading in terms of revenue 123.29 USD Million in 2024
    • Key Country: Malaysia, leading in terms of revenue with value of 123.29 USD Million in 2024.

Segments and Scope

  • Malaysia Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 214.52 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 6.42 % in forecast period 2025-2032.
  • Malaysia Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 58.03 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 6.90 % in forecast period 2025-2032.
  • Malaysia Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 53.29 USD Million in the year 2024.
    • Oral is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 7.18 % in forecast period 2025-2032.
  • Malaysia Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 61.78 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 6.85 % in forecast period 2025-2032.
  • Malaysia Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 89.24 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 6.56 % in forecast period 2025-2032.
  • Malaysia Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Malaysia Influenza Drug Market to 2032 with a revenue of 68.62 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Malaysia Influenza Drug Market to 2032 with a Growth rate of 6.72 % in forecast period 2025-2032.

Malaysia Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
Malaysia Influenza Drug Market Company Share Analysis

Malaysia Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Malaysia Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Malaysia Influenza Drug Market Company Profiling

Malaysia Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Malaysia Influenza Drug Market is segmented based on Segmentation Treatment,Type,Route of Administration,Age,End User,Distribution Channel.
Malaysia Influenza Drug Market was valued at USD 123.29(Revenue in USD Million) in 2022.
Malaysia Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Malaysia Influenza Drug Market, holding a largest market share of 214.52 USD Million in 2024

Malaysia Influenza Drug Market Scope

Malaysia Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Type
  • Influenza C
  • Influenza B
  • Influenza A
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The Malaysia Influenza Drug Market is segmented based on Segmentation Treatment,Type,Route of Administration,Age,End User,Distribution Channel.
Malaysia Influenza Drug Market was valued at USD 123.29(Revenue in USD Million) in 2022.
Malaysia Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Influenza Drug Market for final year is USD 184.00 (USD Million).

Malaysia Influenza Drug Market Company Profiling

Malaysia Influenza Drug Market Company Profiling
Frequently Asked Questions
The Malaysia Influenza Drug Market is segmented based on Segmentation Treatment,Type,Route of Administration,Age,End User,Distribution Channel.
Malaysia Influenza Drug Market was valued at USD 123.29(Revenue in USD Million) in 2022.
Malaysia Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Influenza Drug Market for final year is USD 184.00 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES